Literature DB >> 16207101

Ketamine for conscious sedation in pediatric emergency care.

Rakhee B Mistry1, Milap C Nahata.   

Abstract

The literature concerning the efficacy and safety of ketamine for conscious sedation during procedures in pediatric emergency departments was reviewed. Data were obtained from the Guidelines for Monitoring and Management of Pediatric Patients During and After Sedation for Diagnostic and Therapeutic Procedures developed by the American Academy of Pediatrics Committee on Drugs, and from a MEDLINE search (January 1966-July 2004). Search terms were conscious sedation, ketamine, and emergency department; articles relevant to pediatric age group were selected. Clinical end points were efficacy and adverse effects associated with ketamine. Ketamine was effective for conscious sedation in 89-100% of patients in various studies using intravenous, intramuscular, or oral routes of administration. The efficacy of ketamine was similar to or greater than that of other drugs, such as midazolam and the combination of meperidine, promethazine, and chlorpromazine. The main adverse effects of ketamine were emesis, recovery agitation, and emergence phenomena. Ketamine appears to be an effective and well-tolerated agent for conscious sedation in pediatric patients. Overall physician and parent satisfaction with the administration of this agent for conscious sedation was high.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207101     DOI: 10.1592/phco.2005.25.8.1104

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  10 in total

1.  What is the evidence for the safety and efficacy of using ketamine in children?

Authors:  G Dolansky; A Shah; G Mosdossy; Mj Rieder
Journal:  Paediatr Child Health       Date:  2008-04       Impact factor: 2.253

2.  An audit of the use of intravenous ketamine for paediatric dental conscious sedation.

Authors:  M N Wood; M C G Manley; N Bezzina; R Hassan
Journal:  Br Dent J       Date:  2015-05-22       Impact factor: 1.626

3.  Effectiveness of pediatric drug-induced sleep endoscopy for REM-predominant obstructive sleep apnea.

Authors:  David F Smith; Shan He; Nithin S Peddireddy; P Vairavan Manickam; Christine H Heubi; Sally R Shott; Aliza P Cohen; Stacey L Ishman
Journal:  Sleep Breath       Date:  2020-04-10       Impact factor: 2.816

4.  Predictors of emesis in children undergoing procedural sedation with intramuscular ketamine in a paediatric emergency department.

Authors:  Shruthi Suryaprakash; Lai Peng Tham
Journal:  Singapore Med J       Date:  2016-12-09       Impact factor: 1.858

Review 5.  What Works and What's Safe in Pediatric Emergency Procedural Sedation: An Overview of Reviews.

Authors:  Lisa Hartling; Andrea Milne; Michelle Foisy; Eddy S Lang; Douglas Sinclair; Terry P Klassen; Lisa Evered
Journal:  Acad Emerg Med       Date:  2016-04-24       Impact factor: 3.451

6.  Procedural moderate sedation with ketamine in pediatric critical care unit.

Authors:  Tarek R Hazwani; Hala Al-Alem
Journal:  Avicenna J Med       Date:  2017 Jan-Mar

Review 7.  Clinical Uses of Ketamine in Children: A Narrative Review.

Authors:  Anoushka Bali; Ashujot Kaur Dang; Daniel A Gonzalez; Rajeswar Kumar; Saba Asif
Journal:  Cureus       Date:  2022-07-20

8.  Efficacy of ketamine in improving pain after tonsillectomy in children: meta-analysis.

Authors:  Hye Kyung Cho; Kyu Won Kim; Yeon Min Jeong; Ho Seok Lee; Yeon Ji Lee; Se Hwan Hwang
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

Review 9.  Pain and anxiety management for pediatric dental procedures using various combinations of sedative drugs: A review.

Authors:  Giath Gazal; Wamiq Musheer Fareed; Muhammad Sohail Zafar; Khalid H Al-Samadani
Journal:  Saudi Pharm J       Date:  2014-04-26       Impact factor: 4.330

10.  Ketamine destabilizes growth of dendritic spines in developing hippocampal neurons in vitro via a Rho‑dependent mechanism.

Authors:  Sufang Jiang; Zimiao Hao; Xuze Li; Lijun Bo; Rui Zhang; Ying Wang; Xiaofeng Duan; Rongtian Kang; Lining Huang
Journal:  Mol Med Rep       Date:  2018-10-02       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.